About Cypress Pharmaceutical
Cypress Pharmaceutical is a Healthcare company based in Madison Heights (United States) founded in 1993, and was acquired by Pernix in November 2012. A variety of generic and branded pharmaceutical formulations are manufactured. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.
Company details
Cypress Pharmaceutical was founded in 1993 in Madison Heights, United States, within the pharmaceutical sector. Operations involve the production of branded products for allergy, respiratory conditions, iron deficiency, nephrology, and pain management. Generic offerings include items for cough and cold, nutritional supplements, analgesics, urinary tract issues, womens health, prenatal vitamins, and dental care. Acquisition by Pernix occurred in 2013.
- Headquarters Madison Heights, United States
- Stage Acquired
- SectorsHealthcare
- Website cypressrx.com
- Social LinkedIn
- Acquired by Pernix (Nov 2012)
Investors in Cypress Pharmaceutical
Cypress Pharmaceutical has secured backing from 1 investor. Prominent investors backing the company include Pernix.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Pharmaceutical company manufacturing and marketing drugs for pediatric market | 1997 | pernixtx.com | The Woodlands, United States |
Investor details for Cypress Pharmaceutical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Cypress Pharmaceutical
2 dated milestones of Cypress Pharmaceutical across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Cypress Pharmaceutical is founded.
- Exit Acquired by Pernix.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Cypress Pharmaceutical (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cypress Pharmaceutical
Cypress Pharmaceutical was founded in 1993.
Cypress Pharmaceutical is headquartered in Madison Heights, United States. It is registered at Madison Heights, Michigan, United States.
Cypress Pharmaceutical was founded in 1993 in Madison Heights, United States, within the pharmaceutical sector. Operations involve the production of branded products for allergy, respiratory conditions, iron deficiency, nephrology, and pain management. Generic offerings include items for cough and cold, nutritional supplements, analgesics, urinary tract issues, womens health, prenatal vitamins, and dental care. Acquisition by Pernix occurred in 2013.
Cypress Pharmaceutical has 1 investor. Key investors include Pernix.
Yes. Cypress Pharmaceutical was acquired by Pernix in November 2012.